Difference between revisions of "Talk:Assessment of the health impacts of H1N1 vaccination"

From Testiwiki
Jump to: navigation, search
(→‎Pandemrix should not be used because of narcolepsy risk: Group E)
m (→‎Pandemrix should not be used because of narcolepsy risk: technical corrections)
Line 19: Line 19:
 
|Resolution=  
 
|Resolution=  
 
|Argumentation =
 
|Argumentation =
−
{{defend|B10 |All data compiled to date indicate that pandemic vaccines including Pandemrix match the excellent safety profile of seasonal influenza vaccines, which have been used for more than 60 years.|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 11:12, 1 April 2011 (EEST)}}
+
{{attack|B10 |All data compiled to date indicate that pandemic vaccines including Pandemrix match the excellent safety profile of seasonal influenza vaccines, which have been used for more than 60 years.|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 11:12, 1 April 2011 (EEST)}}
  
−
{{defend|B11 |Adjuvanted vaccines commonly provide a stronger immune response than unadjuvanted vaccines and also provide a broader immune response allowing for some potential drift of the influenza virus (Pandemrix is an adjuvanted vaccine).|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 11:12, 1 April 2011 (EEST)}}
+
{{attack|B11 |Adjuvanted vaccines commonly provide a stronger immune response than unadjuvanted vaccines and also provide a broader immune response allowing for some potential drift of the influenza virus (Pandemrix is an adjuvanted vaccine).|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 11:12, 1 April 2011 (EEST)}}
  
−
{{defend|B12 |The number of cases of side effects of H1N1 vaccines (including Pandemrix) is in line with normal background rates on a population basis, as reported in a recent study European Medicines Agency |--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 11:12, 1 April 2011 (EEST)}}
+
{{attack|B12 |The number of cases of side effects of H1N1 vaccines (including Pandemrix) is in line with normal background rates on a population basis, as reported in a recent study European Medicines Agency |--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 11:12, 1 April 2011 (EEST)}}
  
 
{{attack|1 |Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}}
 
{{attack|1 |Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}}

Revision as of 08:25, 1 April 2011

Darm exercise 4

Tasks:

  • Make pairs and select one group A-E (D and E have Finnish material).
  • Look at page Discussion for theoretical and practical advice. Also page op_fi:Keskustelun jälkijäsentäminen may be useful.
  • Look at the two or three links on your group's page.
  • Read the texts and try to identify arguments about the use of Pandemrix. Note that arguments can be (and most are) indirect arguments.
  • Rewrite the arguments in such a way that they can be understood outside the original context.
  • Place the arguments into a hierarchical tree of attacking and defending arguments pointing toward the main statement about Pandemrix use.
  • You can also make up your own arguments, or if you have extra time, read additional material (see end of the page).
  • When each group has done their own part, there will be a general discussion about all argumentations by the groups. All argumentations will be merged onto this page based on the discussion.
  • Think: How many readers do you need to make this extra effort of collecting, organising and synthesising information and opinions a worthwhile activity of social learning?

Pandemrix should not be used because of narcolepsy risk

How to read discussions

Statements: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high.

Resolution: Resolution not yet found.

(A stable resolution, when found, should be updated to the main page.)

Argumentation:

⇤B10 : All data compiled to date indicate that pandemic vaccines including Pandemrix match the excellent safety profile of seasonal influenza vaccines, which have been used for more than 60 years. --Oluyemitoyinbo 11:12, 1 April 2011 (EEST)

⇤B11 : Adjuvanted vaccines commonly provide a stronger immune response than unadjuvanted vaccines and also provide a broader immune response allowing for some potential drift of the influenza virus (Pandemrix is an adjuvanted vaccine). --Oluyemitoyinbo 11:12, 1 April 2011 (EEST)

⇤B12 : The number of cases of side effects of H1N1 vaccines (including Pandemrix) is in line with normal background rates on a population basis, as reported in a recent study European Medicines Agency --Oluyemitoyinbo 11:12, 1 April 2011 (EEST)

⇤1 : Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST)

←2 : The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST)

←3 : In Finland, THL decided to stop the use of Pandemrix. --Jouni 23:05, 31 March 2011 (EEST), [1]
⇤E6 : The vaccination used last year will most likely protect also against the possible swine flu epidemic of this year, although the virus has changed a bit. --Sallamari Tynkkynen 10:57, 1 April 2011 (EEST) [2]
←E7 : Vaccination is a very good method of preventing swine flu infections. --Sallamari Tynkkynen 10:59, 1 April 2011 (EEST) [3]
←E8 : WHO recommended that H1N1 virus strain be included in the seasonal flu vaccines for the 2009/2010 season, because H1N1 is still in circulation, but behaving like a seasonal flu virus. --Anna Kokkonen 11:10, 1 April 2011 (EEST) [4]
←E9 : The information supplied on the safety and effectiveness of three of the pandemic-influenza vaccines was considered complete enough for the Agency's Committee for Medicinal Products for Human Use to recommend their use outside a pandemic situation. --Anna Kokkonen 11:10, 1 April 2011 (EEST) [5]

⇤E4 : The side effects of Pandemrix have been accentuated, although the benefits are much more significant. --Sallamari Tynkkynen 10:50, 1 April 2011 (EEST) [6]

⇤E5 : Nursing staff in hospitals should be vaccinated; it is their responsibility as medical professionals. --Sallamari Tynkkynen 10:54, 1 April 2011 (EEST) [7]


Discussion groups:


Additional material:

Retrieved from "http://www.opasnet.org/testiwiki/index.php?title=Talk:Assessment_of_the_health_impacts_of_H1N1_vaccination&oldid=19807"